Table 2.
Patient and tumor characteristics
| Characteristic | # (%) | |
|---|---|---|
| Age, median (range) | 62 (35–89) | |
| Stage (FIGO 1988 system) | IA Grade 3 | 5 (3.2) |
| IB Grade 1 | 9 (5.7) | |
| IB Grade 2 | 48 (30) | |
| IB Grade 3 | 20 (12.7) | |
| IC Grade 1 | 30 (19.1) | |
| IC Grade 2 | 17 (10.8) | |
| IC Grade 3 | 2 (1.2) | |
| IIA Grade 1 | 6 (3.8) | |
| IIA Grade 2 | 2 (1.2) | |
| IIA Grade 3 | 3 (1.9) | |
| IIB Grade 1 | 6 (3.8) | |
| IIB Grade 2 | 3 (1.9) | |
| IIB Grade 1 | 2 (1.2) | |
| IIB Grade 2 | 1 (0.6) | |
| IIB Grade 3 | 3 (1.9) | |
| Stage (FIGO 2009 system) | IA Grade 1 | 15 (9.5) |
| IA Grade 2 | 51 (32.4) | |
| IA Grade 3 | 30 (19.1) | |
| IB Grade 1 | 32 (20.3) | |
| IB Grade 2 | 17 (10.8) | |
| IB Grade 3 | 3 (1.9) | |
| II Grade 1 | 6 (3.8) | |
| II Grade 2 | 3 (1.9) | |
| Myometrial invasion | 0% | 9 (5.7) |
| 1–25% | 59 (37.6) | |
| 26–50% | 47 (28.7) | |
| 51–75% | 32 (20.4) | |
| 76–100% | 10 (6.4) | |
| Lymphatic vessel invasion | Yes | 28 (17.8) |
| Lymphadenectomy | Complete | 121 (77.1) |
| Sampling | 21 (13.4) | |
| No nodes removed | 15 (9.6) | |
| Adjuvant chemotherapy | 5 (3.1) |